SOPHIA GENETICS   SF -,05
SOPHIA GENETICS SF -,05
Share · CH1125843347 · SOPH · A3CVT8 (XNAS)
Overview
No Price
31.10.2025 20:00
Current Prices from SOPHIA GENETICS SF -,05
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
SOPH
USD
31.10.2025 20:00
5,00 USD
-0,19 USD
-3,66 %
Company Profile for SOPHIA GENETICS SF -,05 Share
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Get up to date insights from finAgent about SOPHIA GENETICS SF -,05

Company Data

Name SOPHIA GENETICS SF -,05
Company SOPHiA GENETICS S.A.
Symbol SOPH
Website https://www.sophiagenetics.com
Primary Exchange XNAS Frankfurt
WKN A3CVT8
ISIN CH1125843347
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO Jurgi Camblong
Market Capitalization 209 Mio
Country Switzerland
Currency EUR
Employees 0,4 T
Address Rue du Centre 172, 1025 Rolle
IPO Date 2021-07-23

Ticker Symbols

Name Symbol
Frankfurt 90B.F
NASDAQ SOPH
More Shares
Investors who hold SOPHIA GENETICS SF -,05 also have the following shares in their portfolio:
LB.HESS.-THR. IHS 18/27
LB.HESS.-THR. IHS 18/27 Bond
LB.HESS.THR.CARRARA06E/22
LB.HESS.THR.CARRARA06E/22 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025